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 A b s t r a c t: Objective: The aim of the present study was to determine the 
prevalence of abnormal thyroid function and antithyroid antibodies during pregnancy in 
women with diabetes type 1 and gestational diabetes mellitus (GDM).  
 Methods: The study group included 83 pregnant women who attended the 
Outpatient Department of the Endocrinology, Diabetes and Metabolic Disorders Clinic 
in the period from 05.2009 to 11.2009. The one hundred-g. oral glucose tolerance test 
(OGTT) was conducted on the pregnant women except for women with diabetes type 1. 
Thyroid functions were evaluated in all the pregnant women. After routine screening for 
GDM, thirty of the pregnant women were healthy and GDM was diagnosed in forty of 
them. The rest, thirteen women, had diabetes type 1.  
 Results: The women who developed GDM showed a mean free thyroxin 
concentration (fT4) significantly lower than that observed in the healthy pregnant 
women and women with diabetes type 1. Among the pregnant women with GDM, 10 
women or 25% had fT4 concentrations below the lower cut-off with normal thyroid-
stimulating hormone concentrations (TSH). A statistically significant difference was 
found in the prevalence of antithyroid antibodies (anti-TPO) between the (30%) women 
with diabetes type 1 and (10%) healthy pregnant women (p < 0.05). In the women posi-
tive for anti-TPO, TSH was significantly higher (p < 0.05). 
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 Conclusion: The significantly higher prevalence of hypothyroxinemia in GDM 
pregnancies and anti-TPO titres in pregnancies with diabetes type 1, than in healthy 
pregnant women warrants routine screening for thyroid abnormalities in these groups of 
pregnant women. 
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Introduction 
 
 As an autoimmune disease, type 1 diabetes mellitus can be associated 
with other autoimmune disorders. Autoimmune thyroid disease is the most fre-
quent autoimmune disease associated with type 1 diabetes mellitus. The scre-
ening and diagnosis of autoimmune thyroid disease are based on the assessment 
of anti-TPO [1]. About 10% of women at 16 weeks gestation are positive for 
anti-TPO, in line with what is found in the general population [2]. Thyroid 
dysfunction and anti-TPO in pregnancy are associated with multiple clinically 
relevant events occurring before, during and after pregnancy. The presence of 
anti-TPO during pregnancy may be associated with recurrent abortions, autoim-
mune hypo- and hyperthyroidism in pregnancy and an increased risk of postpar-
tum thyroiditis [3]. Several studies have concluded that anti-TPO occur more 
frequently in pregnant women with diabetes type 1 than in healthy pregnant 
women [4–6]. Although most type 1 diabetic patients are clinically euthyroid, 
screening for anti-TPO has been recommended as there is a risk of developing 
future thyroid dysfunction [7]. However, long-term prospective trials to eva-
luate the incidence and natural history of thyroid disorders in patients with type 
1 diabetes are lacking [8]. Gestational diabetes mellitus (GDM) is associated 
with many non-organ-specific autoantibodies. High titres of anti-TPO in a 
GDM pregnancy could potentially further compromise the known foetal and 
maternal complications associated with GDM [3]. However, few studies have 
investigated the presence of anti-TPO in women with GDM, and no significant 
association between diabetes in pregnancy and thyroid function has been repor-
ted [2, 9]. 
 The aim of the study was to determine the prevalence of thyroid dysfun-
ction and anti-TPO during pregnancy in women with diabetes type 1 and GDM. 
 
 
Methods 
 
 The pregnant women were outpatients of the Endocrinology, Diabetes 
and Metabolic Disorders Department of the University Clinical Hospitalin 
Skopje, R. Macedonia, in the period from 05.2009 to 11.2009. A standard dia-
gnostic 100-g 3-h fasting oral glucose tolerance test (OGTT) was administered. 
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After an overnight fast and at least 3 days of unrestricted diet (≥ 150g carbo-
hydrate per day) and unlimited physical activity, blood was taken to determinate 
plasma glucose levels. According to Carpenter and Coustan’s criteria [10] the 
cut-off values were the following: fasting glycaemia: 5.3 mmol/l, 1 h: 10.0 
mmol/l, 2 h: 8.6 mmol/ l, 3 h: 7.8 mmol/l. GDM was diagnosed if two or more 
of the four threshold plasma glucose values were met or were exceeded. In forty 
women GDM was diagnosed. Thirty healthy pregnant women with a normal 
glucose tolerance after OGTT were recruited as controls. Thirteen women with 
previously diagnosed diabetes type 1 who visited the Clinic were also included 
for analysis. None of the patients and controls had a personal history of thyroid 
disease and none was receiving any medication that could influence thyroid 
function. All the pregnant women taking part in the study gave their written 
consent to be included.  
We investigated the following parameters: patient’s age, body mass 
index (BMI), gestational age, fT4, TSH, anti-TPO, and thyroid ultrasound. All 
parameters were assessed in the groups, at the time of the first visit (for women 
with diabetes type 1), or at the time of OGTT (for other pregnant women).  
 Blood samples were drawn at 08:00am after a 14-hour fast. Serum TSH 
and free T4 concentrations were measured using an Immulite 2000 chemilumi-
nescent analyser (Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA). 
The normal range for TSH were 0.2–4.2 mIU/l and for fT4 10.3–24.45 pmol/l. 
The sensitivity of the assays was 0.004 μIU/ml and 0.3 ng/dl, respectively. Anti-
TPO was determined by immunometric assay obtained from Diagnostic Pro-
ducts Corporation (Los Angeles, CA) and for positive test we obtained anti-
TPO > 34 iU/ml. Ultrasonographic examination of the thyroid was performed 
with a ССА–220, 7.5 MHz linear transducer (Toshiba, Japan), effective length 
62 mm. Echogenicity was evaluated by a standardized comparison of the echo-
genicity of the thyroid with the echogenicity of the adjacent muscles: m. ster-
nohyoideus, m. sternothyroideus and m. sternocleidomastoideus, in a longitudi-
nal scan of the thyroid lobes. 
 Statistical analysis was performed using the Statistics for Windows prog-
ramme, version 5, 0. Data are given as arithmetic mean ± standard deviation and 
percents. ANOVA was used to compare mean values between groups. The 
significance of the differences between anti-TPO positive and negative groups 
was tested using student t-test. The level of significance was set at p < 0.05. 
 
 
Results 
 
 In the total group of 83 subjects, 40 (48.2%) were diagnosed as having 
GDM, 13 (15.7%) were with diabetes type 1, while 30 (36.1%) were classified 
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as normal. Mean maternal age was 30.8 ± 5.1 years. Mean gestational age was 
22.9 ± 8.3 weeks. Comparisons of clinical characteristics of women are shown 
in Table 1. The healthy controls and GDM were of a similar age, gestational age 
and BMI. The women with diabetes type 1 were significantly younger and had a 
lower BMI than the control and GDM groups. Also they visited the hospital 
earlier then other two groups.  
 
Table 1 – Табела 1 
 
Comparisons of clinical characteristics of pregnant women 
Сpоредба на клиничкиtе каракtерисtики на бремениtе жени 
 
Variables Healthy controls (30) 
Diabetes type 
1 (13) GDM (40) p 
age (years) 30,5 ± 5,2 27,4 ± 3,8 32,1 ± 5,1 0,012 
gestational age 
(weeks) 25,4 ± 6,3 12,5 ± 7,2 24,7 ± 7,5 < 0,001 
BMI (kg/m2) 28,5 ± 5,8 24,7 ± 5,1 28,9 ± 6,1 0,011 
fT4 13,8 ± 2,3 13,8 ± 2,1 11,7 ± 2,4 0,0006 
TSH 1,8 ± 1,0 2,2 ± 1,6 1,9 ± 1,3 0,6 
anti-TPO 3 (10%) 4 (30,8%) 6 (15%) – 
BMI – body mass index, fT4 – free thyroxin, TSH – thyroid-stimulating hormone, anti-
TPO – antithyroid peroxides antibody. 
BMI – индекс на телесна маса, fT4 – слободен тироксин, TSH – тиреостимули-
рачки хормон, anti-TPO – антитела против тироидната пероксидаза. 
 
 The women who developed GDM showed a mean fT4 concentration 
significantly lower than that observed in the healthy pregnant women and wo-
men with diabetes type 1. Among the pregnant women with GDM, 10 women 
or 25% had fT4 concentrations bellow the lower cut-off of 10.2 pmol/l (vs. 
3.3% in control group and 7.7% with diabetes type 1).  
 Hypothyroidism was present in only 1 woman (1.2%) who had either 
low fT4 or high TSH and she had GDM. Subclinical hypothyroidism was pre-
sent in 4 women (4.8%) who had normal fT4 and high TSH. Two of them had 
GDM, one had diabetes type 1, and one was from the control group. Summary 
3.3% from the control group, 7.7% with diabetes type 1, and 7.5% with GDM 
had thyroid dysfunction. None had subclinical or clinical hyperthyroidism.  
 Healthy controls who were anti-TPO positive (3/30) had thyroid ultra-
sonografic changes. Two of them had decreased echogenicity, but normal fT4 
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and TSH concentrations. The third had a larger thyroid gland (goitre) and sub-
clinical hypothyroidism. There were differences in the prevalence of anti-TPO 
among the three groups. But only the differences between healthy controls and 
diabetes type 1 were statistically significant (p = 0.04). Anti-TPO were found in 
30.8% (vs. 10%, 15% in healthy controls and GDM, respectively) of pregnant 
women with diabetes type 1.  
  Mean values of fT4 and TSH in the women with and without anti-TPO 
are shown in Table 2. In the women positive for anti-TPO, fT4 were higher (wit 
hout reaching statistical significance) while TSH was significantly higher (p = 
0002).  
 
Table 2 – Табела 2 
 
Thyroid function in women by thyroid antibody status 
Тироидна функција сpоред pрисусtвоtо на анtиtироидниtе анtиtела 
 
Variables anti-TPO positive anti-TPO negative p 
fT4 13,3 ± 2,1 12,7 ± 2,6 0,46 
TSH 3,1 ± 1,8 1,7 ± 1,0 0,002 
 
 
Discussion  
 
 In the present study we found that women with GDM had mean fT4 
concentrations significantly lower than healthy pregnant women and women 
with diabetes type 1. In humans before 20 weeks gestation, when the foetal thy-
roid gland becomes active, the mother is the unique source of thyroid hormones 
[11]. This highlights the importance of adequate maternal thyroid secretion. 
Recently, an increased risk of impaired cognitive development has been repor-
ted, not only in children of women with undetected or inadequately treated thy-
roid deficiency during pregnancy [12], but also in children of pregnant women 
with increased titres of anti-TPO and normal thyroid function [13]. Our results 
showed that pregnant women with GDM and diabetes type 1 have a prevalence 
of anti-TPO (15% and 30% respectively) that is greater than that observed in the 
healthy pregnant women (10%). Only the prevalence of anti-TPO between con-
trols and women with diabetes type 1 was statistically significant. This corres-
ponds with other findings. Ortega-Gonzalez et al. [14] also found no differences 
in the prevalence of anti-TPO among pregnant healthy Mexican women and 
women with GDM. 
 Multiple studies have shown that anti-TPO is present in 10% of women 
at 16 weeks’ gestation [2]. The prevalence in our study was also 10% for heal-
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thy pregnant women, but 15.7% in all 83 pregnant women. This suggests that 
screening for thyroid dysfunction is indicated, especially in women with diabe-
tes type 1. Also, women with anti-TPO positively had statistically higher TSH, 
although their fT4 was lower, the differences did not reach statistical signifi-
cance. No postnatal follow-up was done in women positive for anti-TPO. 
 The problems of hypothyroidism in pregnancy include pregnancy-indu-
ced hypertension, placenta abruption, postpartum haemorrhage, impaired infant 
neurodevelopment and low birth weight. The incidence of hypothyroidism in 
pregnant women is estimated to be 2.5% [15]. Five (6.0%) women in this study 
had hypothyroidism or subclinical hypothyroidism, and 12 (35%) women had 
low fT4, but normal TSH. In the first trimester, hypothyroxinaemia was asso-
ciated with preterm laboir (OR 1.62; 95% CI 1.00–2.62) and macrosomia (OR 
1.97; 95% CI 1.37–2.83) [16]. Although debated, the overall evidence seems to 
suggest that isolated gestational hypothyroxinaemia should be supplemented 
with thyroxin [17]. Glinoer advocates screening of all pregnant women for fT4, 
TSH and anti-TPO. In women with positive anti-TPO but TSH between 2 and 4 
mIU/l, although normal, treatment with thyroxin should be considered [18]. 
Both the American Association of Clinical Endocrinologists and the Endocrine 
Society support thyroid function test screening for all pregnant women. For 
now, there is agreement that further research is much needed in order to provide 
more objective evidence [15]. For the moment there is no consensus for scre-
ening for all pregnant women, but it should be done in high risk groups: chronic 
autoimmune thyroiditis, diabetes mellitus, iodine deficiency, familial history of 
thyroid disease, goitre, previous spontaneous abortion, infertility, and clinical 
signs of hypothyroidism.   
 
 
Conclusion 
 
 Thyroid abnormalities are frequent during pregnancies, especially 
pregnancies complicated with diabetes. The significantly higher prevalence of 
hypothyroxinaemia in GDM pregnancies and anti-TPO titres in pregnancies 
with diabetes type 1, than in healthy pregnant women warrants routine scree-
ning for thyroid abnormalities in these groups of pregnant women. 
 
 
R E F E R E N C E S  
 
1. Prazny M., Skrha J., Limanova Z. et al. (2005): Screening for associated 
autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol. Res; 
54: 41–48. 
 Prevalence of thyroid dysfunction… 57 
Prilozi, Odd. biol. med. nauki, XXXI/2 (2010), 51–59 
2. Olivieri A., Valensise H., Magnani F. et al. (2000): High frequency of 
antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes 
mellitus. European Journal of Endocrinology; 143: 741–747. 
3. Agarwal M.M., Dhatt G.S., Punnose J., Bishawi B., Zayed R. (2006): Thyroid 
function abnormalities and antithyroid antibody prevalence in pregnant women at high 
risk for gestational diabetes mellitus. Gynecological Endocrinology; 22(5): 261–266. 
4. Bech K., Hoier-Madsen M., Feldt-Rasmussen U., Jensen B.M., Molsted-
Pedersen L., Kuhl C. (1991): Thyroid function and autoimmune manifestations in insu-
lin-dependent diabetes mellitus during and after pregnancy. Acta Endocrinologica; 124: 
534–539. 
5. Alvarez-Marfany M., Roman S.H., Drexler A.J., Robertson C., Stagnaro-
Green A. (1994): Long-term prospective study of postpartum thyroid dysfunction in 
women with insulin dependent diabetes mellitus. Journal of Clinical Endocrinology and 
Metabolism; 79: 10–16. 
6. Weetman A.P. (1994): Insulin-dependent diabetes mellitus and post partum 
thyroiditis: an important association (Editorial). Journal of Clinical Endocrinology and 
Metabolism; 79: 7–9. 
7. Chang C-C., Huang C-N., Chuang L-M. (1998): Autoantibodies to thyroid 
peroxidase in patients with type 1 diabetes in Taiwan. European Journal of Endocrino-
logy; 139: 44–48. 
8. Umpierrez G.E., Latif K.A., Murphy M.B. et al. (2003): Thyroid dysfunction 
in patients with type 1 diabetes a longitudinal study. Diabetes Care; 26: 1181–1185. 
9. Lapolla A., Betterle C., Sanzari M. et al. (1996): An immunological and 
genetic study of patients with gestational diabetes mellitus. Acta Diabetologica; 33: 
139–144. 
10. Roggenbruck L., Kleinwechter H.J., Demandt N., Dörner K.M. (2004): 
Diagnostics of gestational diabetes: which cutoff-values are valid for capillary whole 
blood. Clin Lab; 50: 403–408. 
11. Utiger R.D. (1999): Maternal hypothyroidism and fetal development. New 
England Journal of Medicine; 341: 601–602. 
12. Haddow J.E., Palomaki G.E., Allan W.C. et al. (1999): Maternal thyroid 
deficiency during pregnancy and subsequent neuropsychological development of the 
child. New England Journal of Medicine; 341: 549–555. 
13. Pop V.J., de Vries E., van Baar A.L. et al. (1995): Maternal thyroid peroxi-
dase antibodies during pregnancy: a marker of impaired child development? Journal of 
Clinical Endocrinology and Metabolism; 80: 3561–3566. 
14. Ortega-Gonzalez C., Liao-Lo A., Ramirez-Peredo J., Carino N., Lira J., 
Parra A. (2000): Thyroid peroxidase antibodies in Mexican born healthy pregnant wo-
men, in women with type 2 or gestational diabetes mellitus, and in their offspring. 
Endocr Pract; 6: 244–248. 
58 Velkoska Nakova V. et al. 
Contributions, Sec. Biol. Med. Sci., XXXI/2 (2010), 51–59 
15. Lazarus J.H., Kokandi A. (2000): Thyroid disease in relation to pregnancy: 
a decade of change. Clin Endocrinol (Oxf); 53: 265–278. 
16. Cleary-Goldman J., Malone FD., Lambert-Messerlian G. et al. (2008): Ma-
ternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol; 112(1): 85–92. 
17. Pop V.J., Vulsma T. (2005): Maternal hypothyroxinaemia during (early) 
gestation. Lancet; 365: 1604–1606. 
18. Glinoer D. (2003): Management of hypo- and hyperthyroidism during 
pregnancy. Growth Horm IGF Res; 13: S45–S54. 
 
 
Ре з име  
 
ПРЕВАЛЕНЦА НА ТИРОИДНА ДИСФУНКЦИЈА И АВТОИМУНОСТ  
КАЈ БРЕМЕНИ ЖЕНИ СО ГЕСТАЦИСКИ И ТИП 1 ДИЈАБЕТЕС  
 
Велкоска Накова В.,1 Крстевска Б.,2 Димитровски Ч.,2 Симеонова С.,3  
Хаџи-Лега М.,3 Серафимоски В.4 
 
1 Факулtеt за медицински науки, Универзиtеt „Гоце Делчев“,  
Шtиp, Р. Македонија 
2 Клиника за ендокринолоgија, дијабеtес и меtаболни нарушувања,  
Медицински факулtеt, Скоpје, Р. Македонија 
3 Клиника за gинеколоgија и акушерсtво, Медицински факулtеt,  
Скоpје, Р. Македонија 
4 Клиника за gасtроенtерохеpаtолоgија, Медицински факулtеt, 
 Скоpје, Р. Македонија 
 
 
Апс т р а к т: Цел: Да ја одредиме преваленцата на тироидната дисфунк-
ција и антитироидните антитела за време на бременост кај жени со гестациски и 
тип 1 дијабетес. 
Маtеријали и меtоди: Во студијата беа вклучени 83 бремени жени кои 
се јавија на Клиниката за ендокринологија, дијабетес и метаболни нарушувања во 
Скопје, во периодот од мај до ноември 2009. На сите бремени жени, освен оние со 
претходно дијагностициран дијабетес тип 1, им беше направен 100 гр орален глу-
козен толерантен тест (ОГТТ). Тироидната функција им беше испитана на сите 
бремени жени. На рутинскиот скрининг за гестациски дијабетес (ГДМ), триесет 
бремени жени беа здрави, а четириесет имаа ГДМ. Останатите 13 бремени жени 
вклучени во студијата имаа дијабетес тип 1. 
Резулtаtи: Пациентките со ГДМ имаа статистички значајно пониски 
вредности на серумскиот слободен тироксин во споредба со здравите и жените со 
дијабетес тип 1. Помеѓу бремените жени со ГДМ, 10 или 25% имаа концентрации 
на слободен тироксин под долната референтна граница со нормални вредности на 
 Prevalence of thyroid dysfunction… 59 
Prilozi, Odd. biol. med. nauki, XXXI/2 (2010), 51–59 
тиреостимулирачкиот хормон. Статистички значајна разлика пронајдовме во пре-
валенцата на антитироидни пероксидазни антитела (анти-ТПО) помеѓу жените со 
дијабетес тип 1 (30%) и здравите бремени жени (10%), (p < 0,05). Жените кои беа 
позитивни за анти-ТПО, имаа статистички значајно повисока концентрација на 
тиреостимулирачкиот хормон (p < 0,05).   
Заклучок: Статистички значајно повисоката преваленца на хипотирокси-
немија кај ГДМ и анти-ТПО титарот кај бремени жени со дијабетес тип 1 нас-
проти здравите бремени жени, го оправдува рутинскиот скрининг за тироидна 
дисфункција кај бремени жени со дијабетес или присутен ризик фактор за ГДМ. 
 
Клучни зборови: бременост, гестациски дијабетес, дијабетес тип 1, тироидна 
функција, ОГТТ. 
 
 
 
Corresponding Author: 
 
Velkoska Nakova V. 
Faculty of Medical Science,  
Goce Delcev University, 
2000 Stip, R. Macedonia 
 
E-mail: valentina.velkoska@yahoo.com 
 
 
 
 
 
 
 
 
 
 
